Author

J. CRISTANTE

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B. RAGAZZON· 1 shared C. HANTEL· 1 shared J. DENIS· 1 shared L. GUYON· 1 shared N. CHERRADI· 1 shared O. CHABRE· 1 shared S. REDA EL SAYED· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. RAGAZZON

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 10, 2023

Aberrant activation of Wnt/β-Catenin signaling pathway drives the expression of poorprognosis-associated microRNAs in adrenocortical cancer with a major impacton miR-139-5p and its host gene PDE2A

J. CRISTANTE, S. REDA EL SAYED, J. DENIS…·N. CHERRADI

This study shows that Wnt/β-Catenin signaling activation in adrenocortical cancer upregulates poor-prognosis miRNAs, particularly miR-139-5p, which is linked to PDE2A repression and NDRG4 activation.

DOI 10.1101/2023.02.10.527992

humanbulk RNA-seq

𝕏 PostBluesky